Quick Answer
CervoMed Inc. reported Cash And Cash Equivalents At Carrying Value of $8.24 million for the year ending 2025.
- CervoMed Inc. showed a decrease of -8.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CervoMed Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2009: $0.00 | Q2 2010: $58.3 thousand | Q3 2010: $13.0 thousand | Q4 2010: $0.00 | Q2 2011: $5.87 million | Q3 2011: $2.13 million | Q4 2011: $98.4 thousand | Q2 2012: $42.9 thousand | Q3 2012: $156.9 thousand | Q1 2013: $111.4 thousand | Q2 2013: $78.6 thousand | Q3 2013: $255.6 thousand | Q1 2014: $222.1 thousand | Q2 2014: $27.14 million | Q3 2014: $23.79 million | Q1 2015: $3.90 million | Q2 2015: $2.89 million | Q3 2015: $1.90 million | Q1 2016: $5.87 million | Q2 2016: $3.01 million | Q3 2016: $3.02 million | Q1 2017: $12.21 million | Q2 2017: $7.41 million | Q3 2017: $1.22 million | Q1 2018: $16.20 million | Q2 2018: $12.93 million | Q3 2018: $11.02 million | Q4 2018: $7.99 million | Q1 2019: $5.33 million | Q2 2019: $8.37 million | Q3 2019: $6.14 million | Q1 2020: $10.83 million | Q2 2020: $25.56 million | Q3 2020: $21.91 million | Q1 2021: $46.63 million | Q2 2021: $43.31 million | Q3 2021: $40.34 million | Q1 2022: $9.87 million | Q2 2022: $5.97 million | Q3 2022: $6.59 million | Q1 2023: $14.65 million | Q2 2023: $15.00 million | Q3 2023: $10.42 million | Q1 2024: $6.37 million | Q2 2024: $10.01 million | Q3 2024: $7.74 million | Q1 2025: $10.50 million | Q2 2025: $8.32 million | Q3 2025: $9.44 million.
- Over the full 15 years of available data (2011 to 2025), CervoMed Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 8,265.2%.
- Historical annual values: Fiscal year 2025: $8.24 million | Fiscal year 2024: $9.00 million | Fiscal year 2023: $7.79 million | Fiscal year 2022: $4.09 million | Fiscal year 2021: $37.31 million | Fiscal year 2020: $18.52 million | Fiscal year 2019: $14.18 million | Fiscal year 2018: $7.99 million | Fiscal year 2017: $8.90 million | Fiscal year 2016: $1.55 million | Fiscal year 2015: $2.00 million | Fiscal year 2014: $2.34 million | Fiscal year 2013: $255.0 thousand | Fiscal year 2012: $312.1 thousand | Fiscal year 2011: $98.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: